Fractyl Health (GUTS) News Today $1.15 +0.16 (+15.61%) Closing price 04:00 PM EasternExtended Trading$1.12 -0.02 (-2.17%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Comparing Fractyl Health (NASDAQ:GUTS) and Glaukos (NYSE:GKOS)April 12 at 1:47 AM | americanbankingnews.comFractyl Health reports early data from REVEAL-1 cohort of REMAIN-1 studyApril 2, 2025 | markets.businessinsider.comFractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025April 2, 2025 | insidermonkey.comFractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 DiscontinuationApril 1, 2025 | globenewswire.comWilliam Bradley Acquires 16,129 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) StockFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) Director William Bradley purchased 16,129 shares of Fractyl Health stock in a transaction that occurred on Thursday, March 13th. The stock was acquired at an average cost of $1.26 per share, with a total value of $20,322.54. Following the acquisition, the director now directly owns 16,129 shares of the company's stock, valued at $20,322.54. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.March 18, 2025 | marketbeat.comInsider Buying: Fractyl Health, Inc. (NASDAQ:GUTS) Director Acquires 16,129 Shares of StockMarch 18, 2025 | insidertrades.comFractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q4 2024 Earnings Call TranscriptMarch 9, 2025 | insidermonkey.comFractyl Health, Inc. (NASDAQ:GUTS) Sees Large Increase in Short InterestFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 3,100,000 shares, an increase of 29.2% from the January 31st total of 2,400,000 shares. Based on an average daily volume of 327,700 shares, the short-interest ratio is currently 9.5 days. Currently, 15.1% of the company's stock are sold short.March 6, 2025 | marketbeat.comFRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly EarningsMarch 5, 2025 | nasdaq.comFractyl Health’s Earnings Call: Progress Amid ChallengesMarch 4, 2025 | tipranks.comFractyl Health Reports 2024 Financial Results and Strategic ProgressMarch 3, 2025 | tipranks.comFractyl Health reports Q4 EPS (52c), consensus (44c)March 3, 2025 | markets.businessinsider.comFractyl Health files $300M mixed securities shelfMarch 3, 2025 | markets.businessinsider.comFractyl Health, Inc. (GUTS) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comFractyl Health (NASDAQ:GUTS) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSFractyl Health (NASDAQ:GUTS - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.44) by ($0.08).March 3, 2025 | marketbeat.comFractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 3, 2025 | globenewswire.comFractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025February 24, 2025 | globenewswire.comFractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Decrease in Short InterestFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,400,000 shares, a drop of 12.1% from the January 15th total of 2,730,000 shares. Based on an average daily volume of 355,300 shares, the days-to-cover ratio is presently 6.8 days. Approximately 11.6% of the company's shares are sold short.February 19, 2025 | marketbeat.comBeyond GLP-1s? This biotech is exploring longer-term metabolic treatmentsFebruary 10, 2025 | finance.yahoo.comBank of America Securities Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)February 5, 2025 | markets.businessinsider.comFractyl Health price target lowered to $6 from $13 at BofAFebruary 5, 2025 | markets.businessinsider.comFractyl Health, Inc. (NASDAQ:GUTS) Insider Sells $40,446.26 in StockFebruary 4, 2025 | insidertrades.comJay David Caplan Sells 22,346 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) StockFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) insider Jay David Caplan sold 22,346 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $1.81, for a total value of $40,446.26. Following the completion of the transaction, the insider now directly owns 153,544 shares of the company's stock, valued at approximately $277,914.64. The trade was a 12.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.February 3, 2025 | marketbeat.comInsider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of StockFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) CEO Harith Rajagopalan sold 90,972 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $1.82, for a total transaction of $165,569.04. Following the transaction, the chief executive officer now directly owns 491,329 shares of the company's stock, valued at $894,218.78. This represents a 15.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.February 3, 2025 | marketbeat.comMorgan Stanley Lowers Fractyl Health (NASDAQ:GUTS) Price Target to $10.00Morgan Stanley cut their price objective on Fractyl Health from $18.00 to $10.00 and set an "overweight" rating for the company in a research report on Monday.February 3, 2025 | marketbeat.comFractyl Health, Inc. (GUTS) Receives a Buy from Morgan StanleyFebruary 2, 2025 | markets.businessinsider.comFractyl Health announces increased focus on Revita, Rejuva programsJanuary 31, 2025 | markets.businessinsider.comFractyl Health Reprioritizes Focus on REMAIN-1 StudyJanuary 31, 2025 | tipranks.comFractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025January 31, 2025 | globenewswire.comFractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short InterestFractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 2,570,000 shares, an increase of 16.3% from the December 15th total of 2,210,000 shares. Based on an average daily volume of 330,200 shares, the short-interest ratio is presently 7.8 days. Approximately 12.5% of the company's shares are sold short.January 20, 2025 | marketbeat.comFractyl Health’s Promising Developments and Positive Outlook Justify Buy RatingJanuary 14, 2025 | markets.businessinsider.comFractyl Health announces clinical results from first patient in REVEAL-1 cohortJanuary 14, 2025 | markets.businessinsider.comFractyl Health’s Promising Progress in Weight ManagementJanuary 13, 2025 | tipranks.comGeode Capital Management LLC Acquires 313,335 Shares of Fractyl Health, Inc. (NASDAQ:GUTS)Geode Capital Management LLC grew its holdings in shares of Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) by 166.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 501,476 shares of the company's stock after buyJanuary 10, 2025 | marketbeat.comFractyl Health to present new data on Rejuva Smart GLP-1 programDecember 13, 2024 | markets.businessinsider.comFractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)December 12, 2024 | globenewswire.comFractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)December 9, 2024 | globenewswire.comFractyl Health to Participate in the Upcoming December ConferencesNovember 26, 2024 | globenewswire.comFractyl Health management to meet virtually with B. RileyNovember 20, 2024 | markets.businessinsider.comFractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comFractyl Health, Inc. (GUTS) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.com5 Things to Do When You Wake Up for a Healthy Gut, According to GastroenterologistsNovember 14, 2024 | yahoo.comInsider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) Insider Sells 64,197 Shares of StockNovember 14, 2024 | insidertrades.comFractyl Health’s Strategic Advancements and Promising Data Drive Buy RatingNovember 14, 2024 | markets.businessinsider.comBank of America Securities Sticks to Their Buy Rating for Fractyl Health, Inc. (GUTS)November 14, 2024 | markets.businessinsider.comFractyl Health, Inc.: Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 13, 2024 | finanznachrichten.deFractyl Health Reports Q3 2024 Financial PerformanceNovember 13, 2024 | markets.businessinsider.comFractyl Health Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 12, 2024 | globenewswire.com'Unwanted Gas & Bloating': 6 Gut-Damaging Pantry Foods That Can Cause Inflammation And Weight Gain—Goldfish Crackers, MoreNovember 12, 2024 | yahoo.com3 Ways Your Gut Secretly Affects Your Mental Health—By A PsychologistNovember 9, 2024 | forbes.com Remove Ads Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address GUTS Media Mentions By Week GUTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GUTS News Sentiment▼0.960.78▲Average Medical News Sentiment GUTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GUTS Articles This Week▼33▲GUTS Articles Average Week Remove Ads Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVITA Medical News Nyxoah News Inogen News Electromed News Alpha Tau Medical News Pro-Dex News LENSAR News BrainsWay News Lakeland Industries News TriSalus Life Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GUTS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GUTS Stock Free GUTS Stock Alerts